Gene · 623
Papers2,473
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
541 to 560 of 2,473
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Antihypertensive Drug Use and the Risk of Ovarian Cancer Death among Finnish Ovarian Cancer Patients-A Nationwide Cohort Study. | Cancers (Basel) | 2021 | 33925829 | PubTator, text mining | PubMed |
| Extracellular Vesicles Tune the Immune System in Renal Disease: A Focus on Systemic Lupus Erythematosus, Antiphospholipid Syndrome, Thrombotic Microangiopathy and ANCA-Vasculitis. | Int J Mol Sci | 2021 | 33919576 | PubTator, text mining | PubMed |
| Concomitant beta-blocker use is associated with a reduced rate of remission in patients with rheumatoid arthritis treated with disease-modifying anti-rheumatic drugs: a post hoc multicohort analysis. | Ther Adv Musculoskelet Dis | 2021 | 33912249 | PubTator, text mining | PubMed |
| Paediatrics: how to manage infantile haemangioma. | Drugs Context | 2021 | 33889196 | PubTator, text mining | PubMed |
| Clinical features of hypertensive patients with COVID-19 compared with a normotensive group: Single-center experience in China. | Open Med (Wars) | 2021 | 33869774 | PubTator, text mining | PubMed |
| Exploring the Role of Epicardial Adipose Tissue in Coronary Artery Disease From the Difference of Gene Expression. | Front Physiol | 2021 | 33859569 | PubTator, text mining | PubMed |
| Novel biomarkers of childhood and adolescent obesity. | Hypertens Res | 2021 | 33850307 | PubTator, text mining | PubMed |
| Revisiting Pleiotropic Effects of Type I Interferons: Rationale for Its Prophylactic and Therapeutic Use Against SARS-CoV-2. | Front Immunol | 2021 | 33841439 | PubTator, text mining | PubMed |
| COVID-19: imbalance of multiple systems during infection and importance of therapeutic choice and dosing of cardiac and anti-coagulant therapies. | Mol Biol Rep | 2021 | 33837899 | PubTator, text mining | PubMed |
| Strategies to Improve the Clinical Outcomes for Direct-to-Consumer Pharmacogenomic Tests. | Genes (Basel) | 2021 | 33802585 | PubTator, text mining | PubMed |
| Severe COVID-19 Infection Associated with Endothelial Dysfunction Induces Multiple Organ Dysfunction: A Review of Therapeutic Interventions. | Biomedicines | 2021 | 33801921 | PubTator, text mining | PubMed |
| Kinins and Kinin Receptors in Cardiovascular and Renal Diseases. | Pharmaceuticals (Basel) | 2021 | 33800422 | PubTator, text mining | PubMed |
| An Outline of Renal Artery Stenosis Pathophysiology-A Narrative Review. | Life (Basel) | 2021 | 33799957 | PubTator, text mining | PubMed |
| Dopamine and epinephrine for managing complete atrioventricular block due to nonreperfused acute inferior wall myocardial infarction in a rural hospital: A case report. | SAGE Open Med Case Rep | 2021 | 33796312 | PubTator, text mining | PubMed |
| Renin-angiotensin system blockade in the COVID-19 pandemic. | Clin Kidney J | 2021 | 33796285 | PubTator, text mining | PubMed |
| β-blockers in hemodialysis: simple questions, complicated answers. | Clin Kidney J | 2021 | 33779640 | PubTator, text mining | PubMed |
| Fluid Resuscitation for Refractory Hypotension. | Front Vet Sci | 2021 | 33778035 | PubTator, text mining | PubMed |
| High-dose ACEi might be harmful in COVID-19 patients with serious respiratory distress syndrome by leading to excessive bradykinin receptor activation. | Physiol Int | 2021 | 33764894 | PubTator, text mining | PubMed |
| A comprehensive insight into the role of zinc deficiency in the renin-angiotensin and kinin-kallikrein system dysfunctions in COVID-19 patients. | Saudi J Biol Sci | 2021 | 33746538 | PubTator, text mining | PubMed |
| Cardiovascular Drug Therapy during Interstage After Hybrid Approach: A Single-Center Experience in 51 Newborns with Hypoplastic Left Heart. | Paediatr Drugs | 2021 | 33713024 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/623/papers?page=28